RPL36 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.990200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.464800E-01
Normal-vs-Stage2
8.166000E-01
Normal-vs-Stage3
9.976600E-01
Normal-vs-Stage4
6.105800E-01
Stage1-vs-Stage2
8.002600E-01
Stage1-vs-Stage3
9.371600E-01
Stage1-vs-Stage4
5.252000E-01
Stage2-vs-Stage3
7.866600E-01
Stage2-vs-Stage4
6.904200E-01
Stage3-vs-Stage4
5.591600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.621400E-01
Normal-vs-AfricanAmerican
8.636800E-01
Normal-vs-Asian
6.155200E-01
Caucasian-vs-AfricanAmerican
4.737600E-01
Caucasian-vs-Asian
3.839800E-01
AfricanAmerican-vs-Asian
3.085600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.493800E-01
Normal-vs-Female
8.929200E-01
Male-vs-Female
1.987750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.247600E-01
Normal-vs-Age(41-60Yrs)
9.276800E-01
Normal-vs-Age(61-80Yrs)
7.809000E-01
Normal-vs-Age(81-100Yrs)
2.271400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.329000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.204400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.804370E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.024750E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.571800E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.282000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.160600E-01
Normal-vs-Daily Drinker
4.117400E-01
Normal-vs-Weekly Drinker
6.655000E-01
Normal-vs-Occasional Drinker
7.550000E-01
Normal-vs-Social Drinker
7.593000E-01
Non Drinker-vs-Daily Drinker
9.277900E-02
Non Drinker-vs-Weekly Drinker
3.993800E-01
Non Drinker-vs-Occasional Drinker
7.744200E-01
Non Drinker-vs-Social Drinker
2.789000E-01
Daily Drinker-vs-Weekly Drinker
6.539200E-01
Daily Drinker-vs-Occasional Drinker
2.541600E-01
Daily Drinker-vs-Social Drinker
3.370400E-02
Weekly Drinker-vs-Occasional Drinker
4.386800E-01
Weekly Drinker-vs-Social Drinker
2.897200E-01
Occasional Drinker-vs-Social Drinker
2.602400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.659600E-01
Normal-vs-Grade 2
9.105200E-01
Normal-vs-Grade 3
9.577800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.446000E-01
Grade 1-vs-Grade 3
9.720200E-01
Grade 1-vs-Grade 4
9.659600E-01
Grade 2-vs-Grade 3
8.649800E-01
Grade 2-vs-Grade 4
9.105200E-01
Grade 3-vs-Grade 4
9.577800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.768800E-01
Normal-vs-NonDiabetic
7.436400E-01
Diabetic-vs-NonDiabetic
6.966600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.216000E-01
Normal-vs-NoPancreatitis
7.638600E-01
Pancreatitis-vs-NoPancreatitis
9.397800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.071800E-01
Normal-vs-N1
8.473400E-01
N0-vs-N1
5.782000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.635800E-01
Normal-vs-TP53-NonMutant
8.982600E-01
TP53-Mutant-vs-TP53-NonMutant
8.636400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
